BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30115028)

  • 41. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
    Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
    Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of life in advanced renal disease managed either by haemodialysis or conservative care in older patients.
    McKeaveney C; Witham M; Alamrani AO; Maxwell AP; Mullan R; Noble H; Shields J; Reid J
    BMJ Support Palliat Care; 2023 Mar; 13(1):87-94. PubMed ID: 32917654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experiences of US Nephrologists in the Delivery of Conservative Care to Patients With Advanced Kidney Disease: A National Qualitative Study.
    Wong SPY; Boyapati S; Engelberg RA; Thorsteinsdottir B; Taylor JS; O'Hare AM
    Am J Kidney Dis; 2020 Feb; 75(2):167-176. PubMed ID: 31570175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel conservative management of chronic kidney disease via dialysis-free interventions.
    Zarantonello D; Rhee CM; Kalantar-Zadeh K; Brunori G
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):97-107. PubMed ID: 33186220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive Impairment in Non-Dialysis-Dependent CKD and the Transition to Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Harhay MN; Xie D; Zhang X; Hsu CY; Vittinghoff E; Go AS; Sozio SM; Blumenthal J; Seliger S; Chen J; Deo R; Dobre M; Akkina S; Reese PP; Lash JP; Yaffe K; Kurella Tamura M;
    Am J Kidney Dis; 2018 Oct; 72(4):499-508. PubMed ID: 29728316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival of patients ≥70 years with advanced chronic kidney disease: Dialysis vs. conservative care.
    Martínez Echevers Y; Toapanta Gaibor NG; Nava Pérez N; Barbosa Martin F; Montes Delgado R; Guerrero Riscos MÁ
    Nefrologia; 2016; 36(3):283-91. PubMed ID: 27102267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis.
    Molnar MZ; Streja E; Sumida K; Soohoo M; Ravel VA; Gaipov A; Potukuchi PK; Thomas F; Rhee CM; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1428-1437. PubMed ID: 28679562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients.
    Nguyen HV; Bose S; Finkelstein E
    BMC Nephrol; 2016 Apr; 17(1):45. PubMed ID: 27121505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
    Yusuf AA; Howell BL; Powers CA; St Peter WL
    Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.
    Chen PM; Lai TS; Chen PY; Lai CF; Yang SY; Wu V; Chiang CK; Kao TW; Huang JW; Chiang WC; Lin SL; Hung KY; Chen YM; Chu TS; Wu MS; Wu KD; Tsai TJ
    Am J Med; 2015 Jan; 128(1):68-76. PubMed ID: 25149427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand.
    Anutrakulchai S; Mairiang P; Pongskul C; Thepsuthammarat K; Chan-On C; Thinkhamrop B
    BMC Health Serv Res; 2016 Sep; 16(1):528. PubMed ID: 27686066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary care physicians' perceived barriers, facilitators and strategies to enhance conservative care for older adults with chronic kidney disease: a qualitative descriptive study.
    Tam-Tham H; Hemmelgarn BR; Campbell DJ; Thomas CM; Fruetel K; Quinn RR; King-Shier KM
    Nephrol Dial Transplant; 2016 Nov; 31(11):1864-1870. PubMed ID: 26681733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized controlled trial to evaluate and assess the effect of comprehensive pre-end stage kidney disease education on home dialysis use in veterans, rationale and design.
    Shukla AM; Hale-Gallardo J; Orozco T; Freytes I; Purvis Z; Romero S; Jia H
    BMC Nephrol; 2022 Mar; 23(1):121. PubMed ID: 35354430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dialysis versus Medical Management at Different Ages and Levels of Kidney Function in Veterans with Advanced CKD.
    Kurella Tamura M; Desai M; Kapphahn KI; Thomas IC; Asch SM; Chertow GM
    J Am Soc Nephrol; 2018 Aug; 29(8):2169-2177. PubMed ID: 29789430
    [No Abstract]   [Full Text] [Related]  

  • 56. A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients.
    Cho JH; Jang HM; Jung HY; Choi JY; Park SH; Kim CD; Yang CW; Jin DC; Kim YL
    Clin Ther; 2018 Jan; 40(1):123-134. PubMed ID: 28291581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing key cost drivers associated with caring for chronic kidney disease patients.
    Damien P; Lanham HJ; Parthasarathy M; Shah NL
    BMC Health Serv Res; 2016 Dec; 16(1):690. PubMed ID: 28031020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trial.
    Knowles SR; Ski CF; Langham R; O'Flaherty E; Thompson DR; Rossell SL; Moore G; Hsueh YS; Castle DJ
    Trials; 2016 Sep; 17(1):447. PubMed ID: 27612446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review.
    Buur LE; Madsen JK; Eidemak I; Krarup E; Lauridsen TG; Taasti LH; Finderup J
    BMC Nephrol; 2021 Sep; 22(1):307. PubMed ID: 34507554
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.